---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-017102"
form_type: "8-K"
ticker: null
cik: "0001506928"
company_name: "Avinger Inc"
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T22:58:08.095673+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Avinger Q1 2024 revenue flat at $1.9M; gross margin drops to 18%, net loss widens to $5.5M

## Summary
- Revenue $1.9M unchanged YoY and QoQ; gross margin fell to 18% from 34% in Q1 2023.
- Net loss of $5.5M vs $4.6M in Q1 2023; operating expenses rose to $5.4M.
- Secured up to $15M equity funding from Zylox-Tonbridge; $7.5M funded in March 2024.
- Initiated Phase III studies for coronary CTO-crossing system; IDE submission expected Q3 2024.
- Exchanged $61M Series A preferred stock for new Series A-1 with $10M value and no liquidation preference.

## SEC filing metadata
- accession: 0001437749-24-017102
- form_type: 8-K
- cik: 0001506928
- company_name: Avinger Inc
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506928/000143774924017102/0001437749-24-017102-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506928/000143774924017102/avgr20240514_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-017102
- JSON: https://secwatch.observer/filing/0001437749-24-017102.json
- Plain text: https://secwatch.observer/filing/0001437749-24-017102.txt

## Key facts
- Earnings Releases
  Avinger Inc reported first quarter ended March 31, 2024 results: revenue $1.9 million, net income $5.5 million.
  - Period: first quarter ended March 31, 2024
  - Revenue: $1.9 million
  - Net income: $5.5 million
  - Result: reported results
  source text: treatment of vascular disease, today reported results for the first quarter ended March 31, 2024. First Quarter and Recent Highlights ● Reported first quarter 2024 revenue of $1.9 million, and gross margin of 18% ● Continued full commercial launch of Tigereye ST, Avinger’s most advanced image-guided peripheral CTO-crossing device, and limited launch of the new
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506928/000143774924017102/0001437749-24-017102-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.